@article{Herrera_2021,
title={Brentuximab Vedotin Plus Cyclophosphamide,
Doxorubicin,
Etoposide,
and Prednisone (CHEP-BV) Followed By BV Consolidation in Patients with CD30-Expressing Peripheral T-Cell Lymphomas},
volume={138},
ISSN={1528-0020},
url={http://dx.doi.org/10.1182/blood-2021-151105},
DOI={10.1182/blood-2021-151105},
number={Supplement 1},
journal={Blood},
publisher={American Society of Hematology},
author={Herrera,
Alex F. and Zain,
Jasmine and Savage,
Kerry J. and Feldman,
Tatyana A. and Brammer,
Jonathan E and Chen,
Lu and Popplewell,
Leslie L. and Budde,
Lihua E and Mei,
Matthew and Leslie,
Lori A. and Nair,
Ranjit and Hosing,
Chitra and Peters,
Lacolle and Forman,
Stephen J and Rosen,
Steven T. and Kwak,
Larry W. and Iyer,
Swaminathan P},
year={2021},
month=nov,
pages={133–133} }